{
  "uid": "b292ec84",
  "metadata": {
    "Full_Name": "solomon",
    "Age": "78",
    "Gender": "Female",
    "Systolic": "180",
    "Diastolic": "110",
    "Glucose_Level": "376",
    "BMI": "30.8",
    "Duration": "16",
    "Smoking": "Yes",
    "Hypertension": "Yes",
    "Family_History": "Yes",
    "Cholesterol": "230",
    "HbA1c": "8.6",
    "Insulin_Use": "Yes",
    "Physical_Activity": "1",
    "Medication": "Yes"
  },
  "prediction": {
    "predicted_stage": "SEVERE",
    "confidence": 82.87,
    "risk_score": 95.54
  },
  "probs": {
    "cnn": [
      0.015175404958426952,
      0.007805488537997007,
      0.01563865877687931,
      0.9413096308708191,
      0.020070824772119522
    ],
    "ml": [
      0.21136369507961952,
      0.20268235745827803,
      0.19376393050773666,
      0.19047474400645248,
      0.20171527294791336
    ],
    "fused": [
      0.04460364817647655,
      0.03703701862682426,
      0.04235744925149287,
      0.8286843922651078,
      0.047317491680098384
    ]
  },
  "lesion_stats": {
    "exudates": 3.112,
    "hemorrhages": 0.732,
    "cotton_wool": 0.002,
    "microaneurysms": 0.531,
    "neovascularization": 2.557,
    "total_lesion_load": 6.934
  },
  "images": {
    "original": "uploads\\b292ec84.png",
    "processed": "static\\processed_images\\b292ec84_processed.png",
    "gradcam": "static/xai_outputs/b292ec84_gradcam.jpg",
    "lime": "static/xai_outputs/b292ec84_lime.png",
    "shap": "static/xai_outputs/b292ec84_shap.png"
  },
  "model_metrics": {
    "Accuracy": 0.947,
    "F1-score": 0.938,
    "AUC/ROC": 0.971
  },
  "generated_at": "2025-11-11T08:18:40.762136+00:00",
  "reports": {
    "patient_en": "Patient: solomon\n\nSummary:\n- Detected stage: Severe.\n- Model confidence: 82.87%\n- Estimated retinal risk score: 95.54%\n\nKey findings and advice:\n1. Maintain regular eye follow-ups as recommended by your clinician.\n2. Tight control of blood sugar and blood pressure reduces progression risk.\n3. Maintain a healthy lifestyle (balanced diet, physical activity, avoid smoking).\n4. If you notice sudden vision changes, floaters, or flashes, seek urgent care.\n\nSevere changes are visible. Please seek ophthalmology review soon for possible specialist management.\n\nPractical precautions:\n- Carry out routine screening exams (as advised).\n- Keep record of blood glucose/HbA1c and bring to appointments.\n\nSincerely,\nVisionAI ‚Äî your digital eye health assistant.",
    "doctor_en": "Clinical Report\n\nPatient stage: Severe\nModel confidence: 82.87%\nRisk score: 95.54%\n\nPatient metadata:\n- Name: solomon\n- Age: 78, Gender: Female\n\nFindings (lesion breakdown):\n- Microaneurysms: 53.10%\n- Exudates: 3.11%\n- Hemorrhages: 73.20%\n- Cotton wool spots: 0.20%\n- Neovascularization: 2.56%\n- Total Lesion Load: 6.93%\n\nClinical interpretation:\n- Extensive hemorrhages/venous beading consistent with severe NPDR; urgent ophthalmology review advised.\n\nModel and explainability:\n- Multi-model fusion: CNN ensemble (EfficientNet, ResNet50, ViT) and metadata models (RF, XGBoost, stacked ensemble).\n- Explainability overlays provided: GradCAM++, LIME, SHAP ‚Äî please review heatmaps and processed images.\n\nPerformance metrics:\n- Accuracy: 0.947\n- F1-score: 0.938\n- AUC/ROC: 0.971\n\nRecommendations:\n1. Correlate with clinical exam and OCT if macular edema suspected.\n2. If PDR suspected, urgent retina referral recommended.\n3. Consider documenting lesion masks/annotations for further audit.\n",
    "research_en": "Research Notes\n\nUID: b292ec84\nPredicted stage: SEVERE\nConfidence: 82.87%\nRisk score: 95.54%\n\nModel stack and fusion:\n- CNN ensemble: EfficientNet, ResNet50, ViT\n- Metadata models: Random Forest, XGBoost, Stacked ensemble\n- Fusion method: weighted averaging with risk calibration\n- Inference device: CPU\n\nLesion stats (approx):\n- Microaneurysms: 53.10%\n- Exudates: 3.11%\n- Hemorrhages: 73.20%\n- Cotton wool spots: 0.20%\n- Neovascularization: 2.56%\n- Total Lesion Load: 6.93%\n\nExplainability summary:\n- GradCAM++ / LIME: highlight posterior pole lesion regions (exudates/hemorrhages).\n- SHAP: systemic features (HbA1c, BMI, BP) often show high importance for risk estimation.\n\nPerformance metrics:\n- Accuracy: 0.947\n- F1-score: 0.938\n- AUC/ROC: 0.971\n\nProbability vectors:\n- CNN probs: [0.015175404958426952, 0.007805488537997007, 0.01563865877687931, 0.9413096308708191, 0.020070824772119522]\n- ML probs: [0.21136369507961952, 0.20268235745827803, 0.19376393050773666, 0.19047474400645248, 0.20171527294791336]\n- Fused probs: [0.04460364817647655, 0.03703701862682426, 0.04235744925149287, 0.8286843922651078, 0.047317491680098384]\n\nResearch recommendations:\n1. Validate lesion segmentation / cotton-wool detection with additional labeled examples and augmentations.\n2. Add cotton-wool-spot specific augmentation and mask labels to address false negatives.\n3. Measure GradCAM / heatmap IoU against human heatmaps for model explainability calibration.\n4. Consider time-series modelling for progression analysis (longitudinal pipeline).\n",
    "patient_kn": "‡≤®‡≤Æ‡≤∏‡≥ç‡≤ï‡≤æ‡≤∞ ‡≤∏‡≥ä‡≤≤‡≥ä‡≤Æ‡≤®‡≥ç,\n\n‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ ‡≤Æ‡≤ß‡≥Å‡≤Æ‡≥á‡≤π ‡≤¨‡≤¶‡≤≤‡≤æ‡≤µ‡≤£‡≥Ü‡≤ó‡≤≥‡≥Å ‡≤ï‡≤Ç‡≤°‡≥Å‡≤¨‡≤∞‡≥Å‡≤§‡≥ç‡≤§‡≤µ‡≥Ü. ‡≤∂‡≥Ä‡≤ò‡≥ç‡≤∞‡≤¶‡≤≤‡≥ç‡≤≤‡≥á ‡≤®‡≤ø‡≤Æ‡≥ç‡≤Æ ‡≤ï‡≤£‡≥ç‡≤£‡≤ø‡≤® ‡≤µ‡≥à‡≤¶‡≥ç‡≤Ø‡≤∞‡≤®‡≥ç‡≤®‡≥Å ‡≤≠‡≥á‡≤ü‡≤ø ‡≤Æ‡≤æ‡≤°‡≥Å‡≤µ‡≥Å‡≤¶‡≥Å ‡≤Æ‡≥Å‡≤ñ‡≥ç‡≤Ø.\n\n‡≤™‡≤§‡≥ç‡≤§‡≥Ü‡≤Ø‡≤æ‡≤¶ ‡≤π‡≤Ç‡≤§: ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ ‡≤°‡≤Ø‡≤æ‡≤¨‡≤ø‡≤ü‡≤ø‡≤ï‡≥ç ‡≤∞‡≥Ü‡≤ü‡≤ø‡≤®‡≥ã‡≤™‡≤§‡≤ø.\n\n‡≤∏‡≤Ç‡≤∂‡≥ã‡≤ß‡≤®‡≥Ü‡≤ó‡≤≥ ‡≤∏‡≤æ‡≤∞‡≤æ‡≤Ç‡≤∂: ‡≤π‡≥ä‡≤∞‡≤∏‡≥Ç‡≤∏‡≥Å‡≤µ‡≤ø‡≤ï‡≥Ü‡≤ó‡≤≥‡≥Å 3.1%, ‡≤π‡≥Ü‡≤Æ‡≤∞‡≥á‡≤ú‡≥ç‡≤ó‡≤≥‡≥Å 73.2%, ‡≤π‡≤§‡≥ç‡≤§‡≤ø ‡≤â‡≤£‡≥ç‡≤£‡≥Ü 0.2%, ‡≤Æ‡≥à‡≤ï‡≥ç‡≤∞‡≥ä‡≤Ö‡≤®‡≥ç‡≤Ø‡≥Ç‡≤∞‡≤ø‡≤∏‡≤Æ‡≥ç‡≤ó‡≤≥‡≥Å 53.1%, ‡≤®‡≤ø‡≤Ø‡≥ã‡≤µ‡≤æ‡≤∏‡≥ç‡≤ï‡≥Å‡≤≤‡≤∞‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç 2.6%, ‡≤í‡≤ü‡≥ç‡≤ü‡≥Å ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤≤‡≥ã‡≤°‡≥ç 6.9%.\n‡≤Æ‡≤æ‡≤¶‡≤∞‡≤ø ‡≤µ‡≤ø‡≤∂‡≥ç‡≤µ‡≤æ‡≤∏: N/A.\n‡≤Ö‡≤™‡≤æ‡≤Ø‡≤ï‡≤æ‡≤∞‡≤ø ‡≤Ö‡≤Ç‡≤∂‡≤ó‡≤≥‡≤®‡≥ç‡≤®‡≥Å ‡≤ó‡≤Æ‡≤®‡≤ø‡≤∏‡≤≤‡≤æ‡≤ó‡≤ø‡≤¶‡≥Ü: ‡≤ß‡≥Ç‡≤Æ‡≤™‡≤æ‡≤®, ‡≤Ö‡≤ß‡≤ø‡≤ï ‡≤∞‡≤ï‡≥ç‡≤§‡≤¶‡≥ä‡≤§‡≥ç‡≤§‡≤°, ‡≤¨‡≥ä‡≤ú‡≥ç‡≤ú‡≥Å (BMI ‚â•30).\n\n‡≤Æ‡≥Å‡≤Ç‡≤¶‡≤ø‡≤® ‡≤π‡≤Ç‡≤§‡≤ó‡≤≥‡≥Å: ‡≤π‡≥Ü‡≤ö‡≥ç‡≤ö‡≤ø‡≤® ‡≤Æ‡≥å‡≤≤‡≥ç‡≤Ø‡≤Æ‡≤æ‡≤™‡≤®‡≤ï‡≥ç‡≤ï‡≤æ‡≤ó‡≤ø ‡≤®‡≥á‡≤§‡≥ç‡≤∞‡≤∂‡≤æ‡≤∏‡≥ç‡≤§‡≥ç‡≤∞‡≤¶ ‡≤Ö‡≤™‡≤æ‡≤Ø‡≤ø‡≤Ç‡≤ü‡≥ç‚Äå‡≤Æ‡≥Ü‡≤Ç‡≤ü‡≥ç ‡≤Ö‡≤®‡≥ç‡≤®‡≥Å ‡≤Ü‡≤¶‡≤∑‡≥ç‡≤ü‡≥Å ‡≤¨‡≥á‡≤ó ‡≤ï‡≤æ‡≤Ø‡≥ç‡≤¶‡≤ø‡≤∞‡≤ø‡≤∏‡≤ø.\n\n‡≤®‡≥Ü‡≤®‡≤™‡≤ø‡≤°‡≤ø - ‡≤Ü‡≤∞‡≤Ç‡≤≠‡≤ø‡≤ï ‡≤ó‡≤Æ‡≤®‡≤µ‡≥Å ‡≤®‡≤ø‡≤Æ‡≥ç‡≤Æ ‡≤¶‡≥É‡≤∑‡≥ç‡≤ü‡≤ø‡≤Ø‡≤®‡≥ç‡≤®‡≥Å ‡≤∏‡≤Ç‡≤∞‡≤ï‡≥ç‡≤∑‡≤ø‡≤∏‡≤≤‡≥Å ‡≤∏‡≤π‡≤æ‡≤Ø ‡≤Æ‡≤æ‡≤°‡≥Å‡≤§‡≥ç‡≤§‡≤¶‡≥Ü. üíô",
    "doctor_kn": "‡≤∏‡≥ä‡≤≤‡≥ä‡≤Æ‡≤®‡≥ç‚Äå‡≤ó‡≤æ‡≤ó‡≤ø VisionAI ‡≤ï‡≥ç‡≤≤‡≤ø‡≤®‡≤ø‡≤ï‡≤≤‡≥ç ‡≤µ‡≤∞‡≤¶‡≤ø (‡≤µ‡≤Ø‡≤∏‡≥ç‡≤∏‡≥Å: 78, BMI: 30.8)\n\n‡≤π‡≤Ç‡≤§: ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ ‡≤°‡≤Ø‡≤æ‡≤¨‡≤ø‡≤ü‡≤ø‡≤ï‡≥ç ‡≤∞‡≥Ü‡≤ü‡≤ø‡≤®‡≥ã‡≤™‡≤§‡≤ø.\n‡≤∏‡≤æ‡≤∞‡≤æ‡≤Ç‡≤∂: ‡≤µ‡≥ç‡≤Ø‡≤æ‡≤™‡≤ï‡≤µ‡≤æ‡≤¶ ‡≤∞‡≤ï‡≥ç‡≤§‡≤∏‡≥ç‡≤∞‡≤æ‡≤µ‡≤ó‡≤≥‡≥Å ‡≤Æ‡≤§‡≥ç‡≤§‡≥Å ‡≤∏‡≤ø‡≤∞‡≥Ü‡≤Ø ‡≤Æ‡≤£‡≤ø‡≤ó‡≤≥‡≥Å - ‡≤∏‡≤Ç‡≤≠‡≤µ‡≤®‡≥Ä‡≤Ø ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ NPDR.\n‡≤∏‡≥ç‡≤µ‡≤Ø‡≤Ç‡≤ö‡≤æ‡≤≤‡≤ø‡≤§ ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤µ‡≤ø‡≤∂‡≥ç‡≤≤‡≥á‡≤∑‡≤£‡≥Ü: ‡≤π‡≥ä‡≤∞‡≤∏‡≥Ç‡≤∏‡≥Å‡≤µ‡≤ø‡≤ï‡≥Ü‡≤ó‡≤≥‡≥Å 3.1%, ‡≤π‡≥Ü‡≤Æ‡≤∞‡≥á‡≤ú‡≥ç‡≤ó‡≤≥‡≥Å 73.2%, ‡≤π‡≤§‡≥ç‡≤§‡≤ø ‡≤â‡≤£‡≥ç‡≤£‡≥Ü 0.2%, ‡≤Æ‡≥à‡≤ï‡≥ç‡≤∞‡≥ä‡≤Ö‡≤®‡≥ç‡≤Ø‡≥Ç‡≤∞‡≤ø‡≤∏‡≤Æ‡≥ç‡≤ó‡≤≥‡≥Å 53.1%, ‡≤®‡≤ø‡≤Ø‡≥ã‡≤µ‡≤æ‡≤∏‡≥ç‡≤ï‡≥Å‡≤≤‡≤∞‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç 2.6%, ‡≤í‡≤ü‡≥ç‡≤ü‡≥Å ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤≤‡≥ã‡≤°‡≥ç 6.9%.\n‡≤µ‡≤ø‡≤∂‡≥ç‡≤µ‡≤æ‡≤∏: N/A, AUC: N/A.\n‡≤µ‡≥ç‡≤Ø‡≤µ‡≤∏‡≥ç‡≤•‡≤ø‡≤§ ‡≤Ö‡≤™‡≤æ‡≤Ø‡≤ó‡≤≥‡≤®‡≥ç‡≤®‡≥Å ‡≤ó‡≥Å‡≤∞‡≥Å‡≤§‡≤ø‡≤∏‡≤≤‡≤æ‡≤ó‡≤ø‡≤¶‡≥Ü: ‡≤ß‡≥Ç‡≤Æ‡≤™‡≤æ‡≤®, ‡≤Ö‡≤ß‡≤ø‡≤ï ‡≤∞‡≤ï‡≥ç‡≤§‡≤¶‡≥ä‡≤§‡≥ç‡≤§‡≤°, ‡≤¨‡≥ä‡≤ú‡≥ç‡≤ú‡≥Å (BMI ‚â•30).\n\n‡≤∂‡≤ø‡≤´‡≤æ‡≤∞‡≤∏‡≥Å: ‡≤§‡≥Å‡≤∞‡≥ç‡≤§‡≥Å ‡≤®‡≥á‡≤§‡≥ç‡≤∞‡≤∂‡≤æ‡≤∏‡≥ç‡≤§‡≥ç‡≤∞‡≤¶ ‡≤â‡≤≤‡≥ç‡≤≤‡≥á‡≤ñ; ‡≤µ‡≥ç‡≤Ø‡≤µ‡≤∏‡≥ç‡≤•‡≤ø‡≤§ ‡≤Ü‡≤™‡≥ç‡≤ü‡≤ø‡≤Æ‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç.\n\n‡≤ó‡≤Æ‡≤®‡≤ø‡≤∏‡≤ø: ‡≤ï‡≥ç‡≤≤‡≤ø‡≤®‡≤ø‡≤ï‡≤≤‡≥ç ‡≤∏‡≤Ç‡≤∂‡≥ã‡≤ß‡≤®‡≥Ü‡≤ó‡≤≥‡≥Å ‡≤Æ‡≤§‡≥ç‡≤§‡≥Å ‡≤∞‡≥ã‡≤ó‡≤ø‡≤Ø ‡≤á‡≤§‡≤ø‡≤π‡≤æ‡≤∏‡≤¶‡≥ä‡≤Ç‡≤¶‡≤ø‡≤ó‡≥Ü ‡≤™‡≤∞‡≤∏‡≥ç‡≤™‡≤∞ ‡≤∏‡≤Ç‡≤¨‡≤Ç‡≤ß‡≤ø‡≤∏‡≤ø. ‡≤≤‡≤≠‡≥ç‡≤Ø‡≤µ‡≤ø‡≤¶‡≥ç‡≤¶‡≤∞‡≥Ü Grad-CAM ‡≤π‡≥Ä‡≤ü‡≥ç‚Äå‡≤Æ‡≥ç‡≤Ø‡≤æ‡≤™‡≥ç‚Äå‡≤ó‡≤≥‡≤®‡≥ç‡≤®‡≥Å ‡≤™‡≤∞‡≤ø‡≤∂‡≥Ä‡≤≤‡≤ø‡≤∏‡≤ø.",
    "research_kn": "‡≤µ‡≤ø‡≤∑‡≤Ø: ‡≤∏‡≥ä‡≤≤‡≥ä‡≤Æ‡≤®‡≥ç\n‡≤®‡≤ø‡≤∞‡≥Ä‡≤ï‡≥ç‡≤∑‡≤ø‡≤§ ‡≤π‡≤Ç‡≤§: ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞\n‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤∏‡≤æ‡≤∞‡≤æ‡≤Ç‡≤∂: ‡≤π‡≥ä‡≤∞‡≤∏‡≥Ç‡≤∏‡≥Å‡≤µ‡≤ø‡≤ï‡≥Ü 3.1%, ‡≤∞‡≤ï‡≥ç‡≤§‡≤∏‡≥ç‡≤∞‡≤æ‡≤µ‡≤ó‡≤≥‡≥Å 73.2%, ‡≤π‡≤§‡≥ç‡≤§‡≤ø ‡≤â‡≤£‡≥ç‡≤£‡≥Ü 0.2%, ‡≤Æ‡≥à‡≤ï‡≥ç‡≤∞‡≥ä‡≤Ö‡≤®‡≥ç‡≤Ø‡≥Ç‡≤∞‡≤ø‡≤Æ‡≥ç‡≤∏‡≥ç 53.1%, ‡≤®‡≤ø‡≤Ø‡≥ã‡≤µ‡≤æ‡≤∏‡≥ç‡≤ï‡≥Å‡≤≤‡≤∞‡≥à‡≤∏‡≥á‡≤∂‡≤®‡≥ç 2.6%, ‡≤í‡≤ü‡≥ç‡≤ü‡≥Å ‡≤ó‡≤æ‡≤Ø‡≤¶ ‡≤π‡≥ä‡≤∞‡≥Ü 6.9%\n‡≤Æ‡≤æ‡≤¶‡≤∞‡≤ø ‡≤µ‡≤ø‡≤∂‡≥ç‡≤µ‡≤æ‡≤∏: N/A, AUC: N/A, GradCAM: ‡≤≤‡≤≠‡≥ç‡≤Ø‡≤µ‡≤ø‡≤≤‡≥ç‡≤≤\n\n‡≤µ‡≤ø‡≤∂‡≥ç‡≤≤‡≥á‡≤∑‡≤£‡≤æ‡≤§‡≥ç‡≤Æ‡≤ï ‡≤ü‡≤ø‡≤™‡≥ç‡≤™‡≤£‡≤ø‡≤ó‡≤≥‡≥Å: ‡≤π‡≥Ü‡≤ö‡≥ç‡≤ö‡≤ø‡≤® ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤∏‡≤æ‡≤Ç‡≤¶‡≥ç‡≤∞‡≤§‡≥Ü ‡≤Æ‡≤§‡≥ç‡≤§‡≥Å ‡≤π‡≥Ä‡≤ü‡≥ç‚Äå‡≤Æ‡≥ç‡≤Ø‡≤æ‡≤™‡≥ç ‡≤ï‡≤µ‡≤∞‡≥á‡≤ú‡≥ç; ‡≤§‡≥Ä‡≤µ‡≥ç‡≤∞ NPDR ‡≤∏‡≤Ç‡≤≠‡≤µ‡≤®‡≥Ä‡≤Ø‡≤§‡≥Ü‡≤Ø ‡≤ï‡≤∞‡≥ç‡≤µ‡≥ç‚Äå‡≤ó‡≥Ü ‡≤π‡≥ä‡≤Ç‡≤¶‡≤ø‡≤ï‡≥Ü‡≤Ø‡≤æ‡≤ó‡≥Å‡≤µ ‡≤Æ‡≤æ‡≤¶‡≤∞‡≤ø.\n\n‡≤∏‡≤Ç‡≤∂‡≥ã‡≤ß‡≤®‡≤æ ‡≤∂‡≤ø‡≤´‡≤æ‡≤∞‡≤∏‡≥Å‡≤ó‡≤≥‡≥Å:\n- ‡≤™‡≤∞‡≤ø‡≤£‡≤ø‡≤§ ‡≤Æ‡≥Å‡≤ñ‡≤µ‡≤æ‡≤°‡≤¶‡≥ä‡≤Ç‡≤¶‡≤ø‡≤ó‡≥Ü ‡≤≤‡≥Ü‡≤∏‡≤ø‡≤Ø‡≤æ‡≤®‡≥ç ‡≤∏‡≥Ü‡≤ó‡≥ç‡≤Æ‡≥Ü‡≤Ç‡≤ü‡≥á‡≤∂‡≤®‡≥ç ‡≤Ö‡≤§‡≤ø‡≤ï‡≥ç‡≤∞‡≤Æ‡≤£‡≤µ‡≤®‡≥ç‡≤®‡≥Å ‡≤Æ‡≥å‡≤≤‡≥ç‡≤Ø‡≥Ä‡≤ï‡≤∞‡≤ø‡≤∏‡≤ø.\n- ‡≤π‡≤Ç‡≤§‡≤¶ ‡≤∏‡≤Æ‡≤§‡≥ã‡≤≤‡≤®‡≤µ‡≤®‡≥ç‡≤®‡≥Å ‡≤∏‡≥Å‡≤ß‡≤æ‡≤∞‡≤ø‡≤∏‡≤≤‡≥Å ‡≤Æ‡≥Å‡≤Ç‡≤¶‡≤ø‡≤® ‡≤Æ‡≤∞‡≥Å‡≤§‡≤∞‡≤¨‡≥á‡≤§‡≤ø ‡≤¨‡≥ç‡≤Ø‡≤æ‡≤ö‡≥ç‚Äå‡≤®‡≤≤‡≥ç‡≤≤‡≤ø ‡≤∏‡≥á‡≤∞‡≤ø‡≤∏‡≤ø.\n- ‡≤Æ‡≤æ‡≤®‡≤µ ‡≤ó‡≥ç‡≤∞‡≥á‡≤°‡≤ø‡≤Ç‡≤ó‡≥ç ‡≤π‡≥Ä‡≤ü‡≥ç‚Äå‡≤Æ‡≥ç‡≤Ø‡≤æ‡≤™‡≥ç‚Äå‡≤ó‡≤≥ ‡≤µ‡≤ø‡≤∞‡≥Å‡≤¶‡≥ç‡≤ß GradCAM ‡≤™‡≥ç‡≤∞‡≤¶‡≥á‡≤∂‡≤¶ ‡≤®‡≤ø‡≤∑‡≥ç‡≤†‡≥Ü‡≤Ø‡≤®‡≥ç‡≤®‡≥Å ‡≤Æ‡≥å‡≤≤‡≥ç‡≤Ø‡≤Æ‡≤æ‡≤™‡≤® ‡≤Æ‡≤æ‡≤°‡≤ø."
  }
}